102 results on '"Swain, Mark"'
Search Results
2. Assessment of fatigue and its impact in chronic liver disease
3. Treatment response and clinical event-free survival in autoimmune hepatitis: A Canadian multicentre cohort study
4. Metabolic dysfunction-associated steatotic liver disease: An opportunity for collaboration between cardiology and hepatology
5. Cholestatic liver disease leads to significant adaptative changes in neural circuits regulating social behavior in mice to enhance sociability
6. A global research priority agenda to advance public health responses to fatty liver disease
7. A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis
8. The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
9. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
10. Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
11. Role of Peripheral Inflammation in Hepatic Encephalopathy
12. Rapid activation and hepatic recruitment of innate-like regulatory B cells after invariant NKT cell stimulation in mice
13. Regulatory T cells suppress sickness behaviour development without altering liver injury in cholestatic mice
14. Role of NKT cells in autoimmune liver disease
15. Mouse mammary tumor virus in anti-mitochondrial antibody producing mouse models
16. WED-274 Impact of sex, body mass index, elevated liver enzymes, and diabetes mellitus on risk-stratification of a large cohort of patients with MASLD
17. TOP-169 Sex, ethnicity and clinical outcomes in autoimmune hepatitis: results from a large multicenter longitudinal cohort
18. LBP-006 Efficacy of elafibranor in primary biliary cholangitis: results from the variable double-blind period of ELATIVE®, a randomised, placebo-controlled phase III trial
19. OS-018 Liver stiffness measurement by vibration-controlled transient elastography predicts adverse clinical outcomes in autoimmune hepatitis: results from a large multicenter longitudinal study
20. Gastrin-releasing peptide and pruritus: More than just scratching the surface
21. Evaluating the role of transient elastography post chronic hepatitis C treatment to predict hepatocellular carcinoma
22. Association Between Endoscopist Specialty and Colonoscopy Quality: A Systematic Review and Meta-analysis.
23. Endogenous opioid-mediated antinociception in cholestatic mice is peripherally, not centrally, mediated
24. A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients
25. SAT-395 - Risk-stratification of patients with non-alcoholic fatty liver disease (NAFLD) in primary care: lessons from the Calgary NAFLD pathway
26. FRI-363 - Loss of innate and adaptive effector lymphocytes is associated with diminished globe score prognosis in patients with primary biliary cholangitis
27. FRI-352 - Cholestatic liver disease enhances sociability and leads to significant adaptative changes in amygdala neural circuits regulating social behavior in mice
28. WED-259 - Vibration-controlled transient elastography predicts clinical outcomes in patients with autoimmune hepatitis
29. FRI-451 - Detrimental association between COVID-19 pandemic stages and alcoholic hepatitis admissions: a Canadian population-based study
30. Impact of the COVID-19 Pandemic on Hospitalizations for Alcoholic Hepatitis or Cirrhosis in Alberta, Canada.
31. Global Incidence of Acute Pancreatitis Is Increasing Over Time: A Systematic Review and Meta-Analysis.
32. THU463 - The prevalence of primary biliary cholangitis (PBC) is on the rise: a canadian population-based study
33. THU462 - Validation of a novel method of identifying patients with Primary Sclerosing Cholangitis (PSC) in a canadian population
34. THU045 - Increased hospital admissions for alcohol-associated hepatitis during the COVID-19 pandemic in Alberta, Canada: a retrospective cohort study
35. OS134 - Quality of life outcomes in patients with primary biliary cholangitis treated with setanaxib: post-hoc results from a phase 2 randomised, placebo-controlled trial
36. Differential leptin responses to acute and chronic biliary obstruction in rats
37. Mo1581 THE NEUTROPHIL-LYMPHOCYTE RATIO ENHANCES LIVER-TRANSPLANTFREE SURVIVAL PREDICTION BEYOND CONVENTIONAL METRICS; A MACHINE LEARNING STUDY.
38. Tu1600 WASTEWATER-BASED SURVEILLANCE OF HEPATITIS E VIRUS ACROSS COMMUNITIES IN ALBERTA, CANADA.
39. Su1790 ACCELERATED INTERMITTENT THETA-BURST STIMULATION TRANSCRANIAL MAGNETIC STIMULATION IS NOT MORE EFFECTIVE THAN SHAM FOR IMPROVING DEPRESSION AND ANXIETY SYMPTOMS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RANDOMIZED, SHAM-CONTROLLED, PILOT TRIAL
40. Sa1806 IMPACT OF INFLAMMATORY BOWEL DISEASE ON BRAIN CORTICAL OXYGEN SATURATION AND FUNCTIONAL CONNECTIVITY: A NOVEL NEAR-INFRARED SPECTROSCOPY INVESTIGATION.
41. SAT134 - The burden of cirrhosis on the Canadian healthcare system: a comparison between alcoholic and non-alcoholic cirrhosis patients
42. FRI436 - Role of pre- and post-treatment transient elastography measurements in predicting hepatocellular carcinoma (HCC) among hepatitis C patients treated with direct acting antivirals (DAAs)
43. FRI133 - Durability of treatment response after 1 year of therapy with seladelpar in patients with primary biliary cholangitis (PBC): final results of an international phase 2 study
44. FRI005 - Performance of non-invasive fibrosis tests among non-alcoholic fatty liver disease (NAFLD) patients with normal alanine aminotransferase (ALT): data from a large North American primary care NAFLD pathway
45. THU227 - A new score including anthropometric measurement for weight improved prediction of mortality in adolescents on the liver transplantation waiting list: a US nationwide study
46. SAT-325-Implementation of a primary care shear-wave elastography-based pathway to identify non-alcoholic fatty liver disease patients with advanced fibrosis in a large North American urban population
47. FRI-309-Hepatitis B virus B and T cell specific responses are reduced in adults with a body mass index > 35 and non-alcoholic fatty liver disease and in a mice model of NAFLD compared to adults with a BMI of > 35 patients and normal animals
48. FRI-056-Obeticholic acid as adjunctive therapy in Primary Biliary Cholangitis: A review of early real-world experience
49. FRI-055-Failure to normalize ALT and IgG in Autoimmune Hepatitis is associated with more advanced liver disease: Perspectives from a multi-ethnic Canadian AIH registry
50. THU-252-Nursing staff volume is the most significant predictor of improved in-hospital mortality among alcoholic hepatitis patients admitted with ascites or hepatic encephalopathy: US nationwide population-based study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.